New collaborative “service innovation” ethos the key to NHS high-value eqpt management
This article was originally published in Clinica
The UK healthcare industry’s initial responses to this week’s parliamentary Public Accounts Committee (PAC) report on managing high-value capital equipment in the NHS in England have revealed the complexity of the issues at hand.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.